MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $3.63 billion. The enterprise value is $3.68 billion.
Important Dates
The next confirmed earnings date is Wednesday, June 3, 2026, before market open.
| Earnings Date | Jun 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 280.82 million shares outstanding.
| Current Share Class | 280.82M |
| Shares Outstanding | 280.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.07% |
| Float | 28.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 42.44 |
| PS Ratio | 1.22 |
| Forward PS | 1.07 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 64.89 |
| PEG Ratio | 1.79 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.23 |
| EV / EBITDA | 16.30 |
| EV / EBIT | 51.90 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.59 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1.95% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $373,625 |
| Profits Per Employee | -$40,000 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MiniMed Group has paid $56.00 million in taxes.
| Income Tax | 56.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 34.04 |
| Average Volume (20 Days) | 919,940 |
Short Selling Information
The latest short interest is 2.86 million, so 1.02% of the outstanding shares have been sold short.
| Short Interest | 2.86M |
| Short Previous Month | 2.75M |
| Short % of Shares Out | 1.02% |
| Short % of Float | 10.20% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, MiniMed Group had revenue of $2.99 billion and -$320.00 million in losses. Loss per share was -$1.14.
| Revenue | 2.99B |
| Gross Profit | 1.70B |
| Operating Income | 71.00M |
| Pretax Income | -243.00M |
| Net Income | -320.00M |
| EBITDA | 226.00M |
| EBIT | 71.00M |
| Loss Per Share | -$1.14 |
Full Income StatementBalance Sheet
The company has $10.00 million in cash and $61.00 million in debt, giving a net cash position of -$51.00 million or -$0.18 per share.
| Cash & Cash Equivalents | 10.00M |
| Total Debt | 61.00M |
| Net Cash | -51.00M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 3.46B |
| Book Value Per Share | 12.33 |
| Working Capital | 412.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $56.00 million and capital expenditures -$224.00 million, giving a free cash flow of -$168.00 million.
| Operating Cash Flow | 56.00M |
| Capital Expenditures | -224.00M |
| Depreciation & Amortization | 155.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -168.00M |
| FCF Per Share | -$0.60 |
Full Cash Flow StatementMargins
Gross margin is 56.74%, with operating and profit margins of 2.38% and -10.71%.
| Gross Margin | 56.74% |
| Operating Margin | 2.38% |
| Pretax Margin | -8.13% |
| Profit Margin | -10.71% |
| EBITDA Margin | 7.56% |
| EBIT Margin | 2.38% |
| FCF Margin | n/a |